Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTRB1 | P17538 | 2/20 | 0.32 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.32 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.32 |
| ▸ | ALPI | P09923 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.31 |
| ▸ | XIAP | P98170 | 1/20 | 0.31 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9219818 | 0.85 | CTRB1 (0.31) | CTRB1MTNR1AMTNR1BALPIPKM | |
| SCHEMBL9215759 | 0.85 | CTRB1 (0.33) | CTRB1MTNR1AMTNR1BALPIPKM | |
| SCHEMBL5476252 | 0.79 | ALPI (0.34) | CTRB1MTNR1AMTNR1BALPIPKM | |
| SCHEMBL9222201 | 0.75 | ALDH1A1 (0.30) | — | |
| SCHEMBL4024044 | 0.73 | CYP1A2 (0.34) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL3155159 | 0.72 | GRIN2D (0.33) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL3145397 | 0.72 | GRIN2D (0.33) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL31016265 | 0.72 | GRIN2D (0.33) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL3136547 | 0.72 | GRIN2D (0.33) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL1660908 | 0.71 | MTNR1A (0.33) | CTRB1MTNR1AMTNR1BALPIPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1995003315-A2 | SACCHARIDES, THEIR SYNTHESIS AND USE | OXFORD GLYCOSYSTEMS LTD (GB) | 1995-02-02 | — | — | WO | disclosed |